Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

13.60
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
11.85
Today|||52-Week Range
19.90
-9.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues34.2M26.6M23.6M24.1M
 
 
 
 
 
Depreciation And Amortization2.2M1.6M2.1M2.0M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses42.4M57.7M59.6M56.7M
 
 
 
 
 
Research And Development26.4M36.1M39.1M37.9M
 
 
 
 
 
Total Operating Expenses44.5M59.2M61.6M58.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.4M-32.6M-38.1M-34.5M
 
 
 
 
 
Extraordinary Credit51.2M0.000.000.00
 
 
Other Expenses65.0K833.0K57.0K39.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income41.5M-31.8M-36.9M-33.2M
 
 
 
 
 
Net Income41.5M-31.8M-36.9M-33.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS69.0M69.7M73.4M74.6M
 
 
 
 
 
Shares To Calculate EPS Diluted69.4M69.7M73.4M74.6M
 
 
 
 
 
 
Earnings Per ShareEPS$0.60-$0.46-$0.50-$0.44
 
 
 
 
 
EPS Diluted$0.60-$0.46-$0.50-$0.44